• Je něco špatně v tomto záznamu ?

Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant®)

J. Rovenský, M. Stančíková, K. Švík, J. Utěšený, K. Bauerová, J. Jurčovičová

. 2009 ; 54 (4) : 359-363.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc09006416

A certain relationship was observed between the gastrointestinal system, arthritis and immune system. Patients with rheumatoid arthritis have an altered microflora composition and disturbed intestinal defensive barrier. Effect of probiotic bacteria (Colinfant®; COL) with known favorable effect on intestinal microflora was determined on the methotrexate (MTX) treatment of adjuvant arthritis. Rats with adjuvant arthritis were administered methotrexate 0.5 mg/kg body mass 2-times weekly per os, COL 1 mL/kg body mass every second day per os, and a combination of MTX+COL for a period of 28 d from the immunization. Levels of serum albumin, body mass, changes in hind paw swelling, and arthrogram score were estimated in rats as variables of inflammation and destructive arthritis-associated changes. Treatment with MTX, as well as with the combination treatment with MTX+COL significantly inhibited both inflammation and destructive arthritis-associated changes. The combination treatment inhibited both the hind paw swelling and arthrogram score more remarkably than MTX alone; on the other hand, the difference between combination treatment and MTX alone was not significant. Treatment with COL alone had no effect on adjuvant arthritis in rats. Colinfant® can increase the preventive effect of MTX treatment in rat adjuvant arthritis by improving its antiarthritic effects.

Bibliografie atd.

Lit.: 27

000      
00000naa 2200000 a 4500
001      
bmc09006416
003      
CZ-PrNML
005      
20130101215631.0
008      
091231s2009 xr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Rovenský, Jozef, $d 1943- $7 xx0006668
245    10
$a Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant®) / $c J. Rovenský, M. Stančíková, K. Švík, J. Utěšený, K. Bauerová, J. Jurčovičová
314    __
$a National Institute of Rheumatic Diseases, Piešťany
504    __
$a Lit.: 27
520    9_
$a A certain relationship was observed between the gastrointestinal system, arthritis and immune system. Patients with rheumatoid arthritis have an altered microflora composition and disturbed intestinal defensive barrier. Effect of probiotic bacteria (Colinfant®; COL) with known favorable effect on intestinal microflora was determined on the methotrexate (MTX) treatment of adjuvant arthritis. Rats with adjuvant arthritis were administered methotrexate 0.5 mg/kg body mass 2-times weekly per os, COL 1 mL/kg body mass every second day per os, and a combination of MTX+COL for a period of 28 d from the immunization. Levels of serum albumin, body mass, changes in hind paw swelling, and arthrogram score were estimated in rats as variables of inflammation and destructive arthritis-associated changes. Treatment with MTX, as well as with the combination treatment with MTX+COL significantly inhibited both inflammation and destructive arthritis-associated changes. The combination treatment inhibited both the hind paw swelling and arthrogram score more remarkably than MTX alone; on the other hand, the difference between combination treatment and MTX alone was not significant. Treatment with COL alone had no effect on adjuvant arthritis in rats. Colinfant® can increase the preventive effect of MTX treatment in rat adjuvant arthritis by improving its antiarthritic effects.
650    _2
$a financování organizované $7 D005381
650    _2
$a zvířata $7 D000818
650    _2
$a antirevmatika $x aplikace a dávkování $7 D018501
650    _2
$a artritida experimentální $x farmakoterapie $x imunologie $x terapie $7 D001169
650    _2
$a kombinovaná terapie $7 D003131
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a Escherichia coli $x fyziologie $7 D004926
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methotrexát $x aplikace a dávkování $7 D008727
650    _2
$a probiotika $x aplikace a dávkování $7 D019936
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední LEW $7 D011917
700    1_
$a Stančíková, Mária, $d 1940- $7 xx0099603
700    1_
$a Švík, Karol $7 xx0119737
700    1_
$a Utěšený, Jaroslav $7 xx0104122
700    1_
$a Bauerová, Katarína. $7 xx0267301
700    1_
$a Jurčovičová, Jana $7 xx0103077
773    0_
$w MED00011005 $t Folia microbiologica $g Roč. 54, č. 4 (2009), s. 359-363 $x 0015-5632
910    __
$a ABA008 $b A 2403 $c 561 $y 8
990    __
$a 20091230090615 $b ABA008
991    __
$a 20130101215817 $b ABA008
999    __
$a ok $b bmc $g 702230 $s 564659
BAS    __
$a 3
BMC    __
$a 2009 $b 54 $c 4 $d 359-363 $i 0015-5632 $m Folia microbiologica $x MED00011005
LZP    __
$a 2009-61/ipme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...